The relationship between dermatology and aesthetic medicine is one of the most compelling issues in recent years. Dermatology ...

The company will use the capital to develop its R&D and technology capabilities, proprietary processes, scale-up capabilities ...

Dr Villoo Morawala Patell, founder of Avesthagen and Avestagenome Project International, discusses how India can turn its ...

As production becomes more complex and highly regulated, digitalisation and automation are emerging as critical enablers. G ...

Zydus Lifesciences (Zydus) and Formycon AG (Formycon) have announced that the US Food and Drug Administration (USFDA) has accepted for review the Biologics License Application (BLA) for FYB206, a ...

The US remains a key market for Indian pharma. But changing conditions are pushing India to diversify its global footprint.

Cohance Lifesciences, a technology-driven, integrated contract development and manufacturing organisation (CDMO), has ...

Akums Drugs & Pharma Ltd., a contract development and manufacturing organisation (CDMO), has introduced a portfolio of ...

The VIGOR programme will advance four drug candidates from TRL-4 to TRL-6 over three years, covering preclinical development ...

Granules India Limited (GIL) announced that it has submitted a Paragraph IV certification in connection with its ANDA for ...

Suneela Thatte, VP & Head, Merck Healthcare R&D India in an exclusive conversation with Swati Rana, speaks about the skills ...

According to a Tracxn report, funding in the HealthTech, Life Sciences and Healthcare sectors in India stood at $256.7M ...